Literature DB >> 27017103

Moving the mandible in orthognathic surgery - A multicenter analysis.

Oliver C Thiele1, Matthias Kreppel2, Gido Bittermann3, Lars Bonitz4, Maria Desmedt5, Carsten Dittes6, Annegret Dörre7, Anton Dunsche8, Alexander W Eckert9, Michael Ehrenfeld10, Bernd Fleiner11, Bernhard Frerich12, Alexander Gaggl13, Marcus Gerressen14, Leonore Gmelin15, Andreas Hammacher16, Stefan Haßfeld4, Max Heiland17, Alexander Hemprich18, Johannes Hidding19, Frank Hölzle20, Hans-Peter Howaldt21, Tateyuki Iizuka22, Wolfgang Kater23, Cornelius Klein24, Martin Klein5, Robert H Köhnke17, Andreas Kolk25, Alexander C Kübler26, Norbert R Kübler27, Martin Kunkel28, Johannes J Kuttenberger29, Thomas Kreusch30, Constantin Landes31, Bernhard Lehner32, Robert A Mischkowski15, Steffen Mokros33, Andreas Neff34, Emeka Nkenke35, Frank Palm36, Gerhard W Paulus37, Jörn U Piesold38, Michael Rasse39, Herbert Rodemer40, Daniel Rothamel2, Jan Rustemeyer41, Robert Sader42, Martin Scheer43, Birgit Scheffler9, Christian Schippers44, Henning Schliephake45, Rainer Schmelzeisen3, Alexander Schramm46, Wolfgang J Spitzer47, Christian Stoll48, Hendrik Terheyden49, Dieter Weingart50, Jörg Wiltfang51, Klaus D Wolff25, Christoph M Ziegler52, Joachim E Zöller2.   

Abstract

Orthognathic surgery has always been a classical focus of maxillofacial surgery. Since more than 100 years, various surgical techniques for mandibular repositioning have been developed and clinically tested. Since the establishment of plate and screw osteosynthesis, orthognathic surgery became more stable and safe. Nowadays, different surgical methods for mobilising the mandible are existing. This international multicenter analysis (n = 51 hospitals) is providing first evidence based data for the current use of different surgical methods. The dominating techniques were Obwegeser/dal Pont (61%) followed by Hunsuck/Epker (37%) and Perthes/Schlössmann (29%). The main osteosynthesis materials were plates (82%), bicortical screws (23.5%), or a combination of both (5.9%). 47% of all centers reported to use several surgical methods at the same time, depending on the anatomical problem and the surgeon's preference. This shows that different surgical methods seem to work as comparable, safe, and reliable procedures in everydays clinical practise. On this basis, further prospective studies could evaluate possible advantages for our patients.
Copyright © 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mandible; Maxillofacial surgery; Orthognathic surgery; Osteosynthesis; Surgical techniques

Mesh:

Year:  2016        PMID: 27017103     DOI: 10.1016/j.jcms.2016.01.024

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  4 in total

1.  Long-Term Study of Relapse After Mandibular Orthognathic Surgery: Advancement Versus Setback.

Authors:  N K Sahoo; Shiv Shankar Agarwal; Sanjeev Datana; S K Bhandari
Journal:  J Maxillofac Oral Surg       Date:  2020-08-31

2.  Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study.

Authors:  Josip Tomic; Jürgen Wallner; Irene Mischak; Gerald Sendlhofer; Wolfgang Zemann; Monika Schanbacher; Hamid Hassanzadeh; Andreas Sandner-Kiesling; Michael Payer; Tomislav A Zrnc
Journal:  Clin Oral Investig       Date:  2022-02-01       Impact factor: 3.606

3.  Quality assessment of patient information on orthognathic surgery on the internet.

Authors:  Johannes Engelmann; Carmen Fischer; Emeka Nkenke
Journal:  J Craniomaxillofac Surg       Date:  2020-05-28       Impact factor: 2.078

4.  Complications or rather side effects? Quantification of patient satisfaction and complications after orthognathic surgery-a retrospective, cross-sectional long-term analysis.

Authors:  Daniel G E Thiem; Daniel Schneider; Michael Hammel; Bassam Saka; Bernhard Frerich; Bilal Al-Nawas; Peer W Kämmerer
Journal:  Clin Oral Investig       Date:  2020-11-06       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.